New to The Street Wellness Interview: Weight Loss Drugs, Long COVID, and Teen Stress
New to The Street TVMay 6, 20251 min1,824 views
5 connectionsΒ·9 entities in this videoβPharmaceutical Innovations in Weight Management
- π Eli Lilly and Company reported profits exceeding expectations, largely driven by the success of its weight loss drug Zepbound.
- π¬ Lilly is also developing a once-daily weight loss pill as an alternative to current injection-based treatments.
- π€ CVS Health has partnered with Novo Nordisk, the maker of Wegovy, to improve the accessibility of their weight loss medication.
Addressing Long COVID Symptoms
- π¦ A biotech company, Biov, is exploring inflammation as a potential target for treating Long COVID.
- π§ͺ Biov's CEO, Kong Do, stated that the company is the sole recipient of a grant to test a therapeutic for Long COVID and has initiated a trial.
- π§ It is estimated that 20 million Americans suffer from Long COVID, experiencing lingering effects such as brain fog and muscle soreness.
Managing Teen Stress and Social Media
- π The phenomenon of elaborate promposals is highlighted as a source of pressure for high school students.
- π± Psychologists suggest that parents can help mitigate stress by encouraging reality checks on social media and reinforcing that it's acceptable not to participate in every trend.
- β οΈ The pressure for over-the-top celebrations, including balloons and flash mobs, is a significant factor contributing to teen stress.
Knowledge graph9 entities Β· 5 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
9 entities
Chapters1 moments
Key Moments
Transcript5 segments
Full Transcript
Topics14 themes
Whatβs Discussed
Weight Loss DrugsZepboundWegovyEli LillyNovo NordiskCVS HealthLong COVIDBiovInflammationBrain FogMuscle SorenessPromposalsTeen StressSocial Media Pressure
Smart Objects9 Β· 5 links
CompaniesΒ· 4
ProductsΒ· 2
EventsΒ· 2
PersonΒ· 1